GlassScriptPhysician profile
Raimonda Goldman
NPI 1639482581
$810.12
in general payments reported to CMS, 2019-2025
11 companies · $48.41 in 2025
The $48.41 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.55 · 2020: $215 · 2021: $334 · 2023: $145 · 2025: $48.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163 · Education: $30.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.13 |
| Education | $30.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $299.89 | 2020-2021 | |
| Sirtex Medical INC | $145.37 | 2023 | Sir-Spheres Microspheres |
| Daiichi Sankyo INC. | $137.98 | 2020-2021 | |
| Janssen Biotech, INC. | $116.76 | 2021-2025 | Rybrevant |
| Pfizer INC. | $30.65 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.80 | 2019 | |
| Genzyme Corporation | $14.87 | 2019 | |
| Merck Sharp & Dohme LLC | $13.49 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Eisai INC. | $11.37 | 2019 | |
| Tesaro, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raimonda Goldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.